Investigation of the anti-cancer drugs imatinib and thalidomide using analytical spectroscopy (FT-IR, UV-Vis) and molecular docking simulations
Cancer is one of the most fatal diseases in modern civilisation, accounting for a significant number of deaths each year. The continued investigation of the medical effects of cancer is still an important and fascinating field of study. Imatinib and Thalidomide are important anti-cancer drugs that a...
Saved in:
| Main Authors: | P. Venkata Ramana, Y. Rama Krishna, Prasadarao Bobbili, K. Venkata Prasad, K. Chandra Mouli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715625003522 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01) -
Design, Docking Analysis, and Structure–Activity Relationship of Ferrocene-Modified Tyrosine Kinase Inhibitors: Insights into BCR-ABL Interactions
by: Irena Philipova, et al.
Published: (2025-07-01) -
Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis
by: I. N. Mikhaylova, et al.
Published: (2021-01-01) -
Replacing the phthalimide core in thalidomide with benzotriazole
by: Mikhail Krasavin, et al.
Published: (2022-12-01) -
BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)